QQ客服 官方微博 反馈留言

	Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d(3) or calcitriol treatment Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China
	Liao, Er-Yuan; Zhang, Zhen-Lin; Xia, Wei-Bo; Lin, Hua; Cheng, Qun; Wang, Li; Hao, Yong-Qiang; Chen, De-Cai; Tang, Hai; Peng, Yong-De
	2018
卷号	97期号:31页码:e11694
关键词	alendronate sodium bone mineral density bone turnover biomarker calcitriol post hoc analysis postmenopausal osteoporosis
ISSN号	0025-7974
DOI	10.1097/MD.0000000000011694
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6356083
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Liao, Er-Yuan,Zhang, Zhen-Lin,Xia, Wei-Bo,et al. Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d(3) or calcitriol treatment Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China[J],2018,97(31):e11694.
APA	Liao, Er-Yuan.,Zhang, Zhen-Lin.,Xia, Wei-Bo.,Lin, Hua.,Cheng, Qun.,...&Zhang, Lei.(2018).Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d(3) or calcitriol treatment Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China.,97(31),e11694.
MLA	Liao, Er-Yuan,et al."Clinical characteristics associated with bone mineral density improvement after 1-year alendronate/vitamin d(3) or calcitriol treatment Exploratory results from a phase 3, randomized, controlled trial on postmenopausal osteoporotic women in China".97.31(2018):e11694.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。